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Abstract 
BACKGROUND: Extensive study has found depression in heart failure (HF) patients to be a 
significant risk factor which has been associated with poor outcomes and increased medical cost 
for this population.  It is highly recommended to screen HF patients for depression to identify 
this important risk factor.  The PHQ-9 depression screening instrument (sensitivity 70% 
specificity 92%) has been identified as a valid measure to detect depression in the HF population.  
Implementing a depression screening protocol in an inpatient environment requires education of 
providers to establish awareness of best practice and foster confidence in their application of the 
screening instrument. OBJECTIVE:  To determine if a correlation exists between provider 
knowledge of depression screening in the HF population, and adherence to a depression 
screening protocol. METHODS: A literature review was conducted to determine appropriate 
depression screening instruments for use in the HF population.  Results were utilized to develop 
an education plan with pre-posttest, and depression screening protocol for implementation.  A 
pilot study was conducted in the critical care unit of Norton Brownsboro Hospital (NBH) from 
September 27, 2017 through October 30, 2017. RESULTS:  Adherence to the screening protocol 
was 40.6 percent.  Pre-post assessment of provider knowledge following provider education was 
correct and unchanged for three out of four knowledge items. Significant (P<.05) increase of 
knowledge (P= .002) for the remaining item.  Perceptions of the burden of untreated/undetected 
depression in the HF population increased significantly (P= .001, P= .04, P= .09). 
CONCLUSIONS: No association between knowledge and adherence to a depression screening 
protocol was found.  Provider knowledge showed significant increase after an education 
intervention.  These results indicate that more is required beyond effective education of providers 
to achieve the goal of depression screening in the inpatient HF population. 
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Background 
Heart failure (HF) is a life-threatening condition where the heart can no longer pump 
blood effectively to the body.  HF is a chronic disease that effects 5.7 million people in the U.S., 
it is a contributing cause to one out of every nine deaths annually in the U.S.; an estimated 20-
40% of people with a diagnosis of heart failure have depression as a comorbidity (Mbakwen, 
Aina, & Amadi, 2016).  Heart disease is the leading cause of disability in the U.S. (CDC, 2011).   
Depression is prevalent in populations with chronic diseases; more specifically depression has 
been found to be independently associated with poor outcomes, specifically risk of readmission, 
in the elderly heart failure population (Freedland et al., 2016).  In chronically ill patients, self-
efficacy is identified as being one of the strongest predictors of health-promoting behaviors and 
is influenced by factors such as social support and depression (Maeda, Shen, Schwarz, Farrell, & 
Mallon, 2013).  Physiologic factors of depression such as lethargy and motor retardation along 
with psychological factors such as pessimism and low self-esteem contribute to poor self-
efficacy behavior in HF patients with comorbid depression leading to nonadherence to HF 
management and consequential rehospitalization (Maeda et al., 2013).   
Both prevalence and cost of care for HF in the U.S. are expected to increase greatly due 
to the aging population; it is estimated that by 2030 more than 8 million Americans will have HF 
with total costs increasing from $31 billion, in 2012, to $70 billion by the year 2030 
(Heidenreich et al., 2013).  Similarly, in 2016, the American Heart Association (AHA) 
commissioned a study to project the burden of cardiovascular disease through the year 2035 
(AHA, 2017).  The report prepared by RTI International projects an estimated 8.8 million 
Americans with HF by the year 2035 and a rise in total cost from $29 billion, in 2015, to $64 
billion by 2035 (Khavjou, Phelps, & Leib, 2016). 
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Prior to recent updates, HF guidelines in the U.S. were adopted, in part, from the Scottish 
Intercollegiate Guidelines Network (SIGN) HF guidelines that were published in 2007, these 
guidelines do not specify depression screening as a necessary measure (SIGN, 2007).  Since that 
time, SIGN has updated their guidelines to include depression screening in the management of 
HF, however, they do not recommend a single preferred screening instrument or treatment 
approach once depression has been identified (SIGN, 2016).  In April 2017, a focused update of 
HF management guidelines was published by the American College of Cardiology (ACC), the 
AHA Task Force on Clinical Practice Guidelines, and the Heart Failure Society of America 
(HFSA). This update also fails to include depression screening as a necessary measure in the 
management of HF (Yancy et al., 2017).  The US Preventive Services Task Force (USPSTF) has 
issued recommendations to screen all adult patients for depression, stating that the harm in doing 
so is “small to none” (Sui, 2016).  HF patients with depression should be comprehensively 
identified due to their increased risk for poor outcomes (Rustad, Stern, Hebert, & Musselman, 
2013).  
Screening Instruments 
To choose an appropriate depression screening instrument for use in the HF population, a 
literature review was completed.  A search of current evidence was done utilizing Medline, 
PubMed, Ebscohost, and CINAHL databases using the terms: depression, heart failure, 
depression screening, depression screening instruments, comorbid depression, readmission, and 
rehospitalization. Results were limited to publications within the past 10 years, English language, 
and age 18+.  
A total of 9 studies met criteria for review.  Rapid appraisal tools were used to verify the 
quality of chosen studies and each were found to be reasonable choices for inclusion.  This was 
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determined by evaluating conflicts of interest and statistical evidence, specifically validity and 
reliability of instruments.  Strength and quality of the 9 chosen pieces of evidence are as follows: 
III-A (4), III-B (2), IV-A (2), IV-B; evidence was evaluated using the Johns Hopkins rating 
scheme (Newhouse et al., 2005).  
The literature review provided evidence that dimensional screening instruments (BDI, 
GDS, HADS, CES-D, DMI-10/18, Zung Depression Scale, Hospital Anxiety and Depression 
Index, PHQ-2, PROMIS, Medical Outcome Survey-Depression Instrument) detect higher rates 
of depressive symptoms where categoric instruments (DIS, CDS) rely on the precision of the 
interviewer to be reliable (Johansson, Dahlstrom, & Brostrom, 2006).  The challenge in choosing 
a screening instrument for this population is compounded by overlapping symptoms such as 
fatigue and loss of appetite which could be attributed to either depression or HF.  The evidence 
revealed that the GDS, BDI, CES-D, HADI, Medical Outcome Survey-Depression Instrument, 
and Zung Depression Scale are all poor instruments for detecting overlap of somatic depressive 
symptoms and physical cardiac symptoms (Delville & Mcdougall, 2008; Haworth, Moniz-Cook, 
Clark, Wang, & Cleland, 2007; Johnson et al.,2012). 
With the goal of applying use of the chosen instrument in the inpatient setting, ease of 
use is also a factor to examine.  The DIS and CDS are instruments that are highly valid and 
reliable however they each require dedicated time and precision for accuracy and would 
therefore be inappropriate for bedside use by staff nurses (Delville & Mcdougall, 2008; Haworth 
et al., 2007; Ski, Thompson, Hare, Stewart, & Watson, 2012).  The remaining evaluated 
instruments, PROMIS- Depression Short Form, PHQ-2, HADS, DMI 10/18 and PHQ-9, vary in 
length and have proved to be valid and reliable (Fischer et al., 2013; Hammash et al., 2012; 
Hilton et al., 2006; Smith, 2010).  Of those instruments the PHQ-9 is selected for its ease of use, 
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in both the outpatient and inpatient setting, and proven ability to detect depression in the adult 
HF population. 
  The PHQ-9 depression screening instrument is both categorical and dimensional and is a 
solid choice considering that it can be used in both inpatient and outpatient settings, as it can be 
provider driven or used in patient self-reporting (Hammash et al., 2012).  In a paper reviewing 8 
separate depression screening instruments the PHQ and BDI were determined to be superior to 
others, however the BDI has already been ruled out for the HF population as it has poor ability to 
discern overlap of symptoms (Ceccarini, Manzoni, & Castelnuovo, 2014).  
After reviewing the literature, the PHQ-9 appears to be a valid instrument for depression 
screening in the inpatient HF population.t. The implementation of depression screening would 
apply to all adult HF patients who are admitted to the inpatient setting.  There is evidence to 
support the use of PHQ-9 screening in the hospitalized HF population; research has found 
positive screening to be associated with an increased 4-year all-cause mortality in patients with 
systolic heart failure specifically (Deveney, Belnap, Mazumdar, & Rollman, 2016). 
The PHQ-9 is practical and valid for the purpose of this study; it has already been chosen 
by Norton Healthcare for use in the stroke patient population and is built into the organization’s 
electronic medical record (EMR) system; it can be added to the chart of any patient admitted to a 
Norton Healthcare facility.  Proven to be valid and reliable the PI has chosen to use the PHQ-9 
depression screening instrument for the adult inpatient HF population (Hammash et al., 2012). 
Purpose 
The specific aim of this study is to evaluate the adherence of staff nurses to a new 
depression screening protocol for the adult inpatient HF population within NBH ICU 3E and 5W, 
following an education intervention.  This pilot study aims to identify if there is a correlation 
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between an education intervention and adherence to a screening protocol.  The following four 
research questions guided this project. 
1. What perceptions do providers hold regarding HF and comorbid depression? 
2. Are providers knowledgeable about the use of the PHQ-9 depression screening 
instrument? 
3. Is there a correlation between education about HF with comorbid depression and 
depression screening in the critical care setting? 
 
Methods 
This project utilized a descriptive quasi-experimental, post-test only evaluation of 
adherence to depression screening in the adult ICU inpatient HF population. This study was 
designed to measure the adherence rate of NBH ICU staff nurses to newly implemented 
depression screening protocol of ICU inpatients, with new or pre-existing diagnosis of HF, using 
the PHQ-9 depression screening instrument after an education intervention. Additionally, this 
study evaluated staff nursing knowledge and perceptions of depression screening using pre/post 
assessment. 
Education of the ICU staff nurses about PHQ-9 depression screening within the adult 
inpatient HF population as well as use of the PHQ-9 in Epic was be provided in face to face 
education sessions, via email and through educational fliers which were posted throughout staff 
common areas.  A baseline/pre-assessment of knowledge and perception concerning depression 
screening (Appendix A) and demographic questionnaire were collected after participant 
recruitment and consent. After receiving education, participating nurses were instructed to utilize 
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the PHQ-9 for any patient they cared for, in the ICU, who had a new or preexisting diagnosis of 
HF.  
A retrospective electronic medical record review was conducted, after patient discharge 
from the unit and at the end of the study period, to evaluate the number of ICU patients, with a 
new or pre-existing diagnosis of HF, who was screened for depression appropriately by 
participating nurse. A post-assessment was given to, and completed by, the consented 
participating staff nurses at the conclusion of the study period to evaluate for a change in 
knowledge and perception of depression screening from baseline measure.  
Setting 
The Norton Healthcare (NH) system is the largest in the Louisville, KY region and 
includes five main hospitals and many urgent care centers offering the residents of Kentucky and 
Southern Indiana a full range of medical services.  Norton Brownsboro Hospital (NBH) is a 175-
bed community hospital located in Jefferson County, Kentucky.  NBH is one of four hospitals 
within the Norton Healthcare systems that serve adult patients.  Consisting of 30 beds the ICU at 
NBH is a collective force of nurses and managers who work between the units of 3 East and 5 
West.  The NBH ICU serves patients admitted with neurologic/neurosurgical, cardiac, 
pulmonary, medical, surgical and renal critical care needs among others.  The study time frame 
was from September 27, 2017 through October 30, 2017. 
Sample 
The study sample consisted of a primary population of providers and a secondary 
population of HF patients.  The primary population for this study includes NBH ICU staff nurses 
who agreed to participate in education sessions and depression screening intervention. Up to 
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approximately 76 staff nurses within the NBH ICU were invited to participate. NBH staff nurses 
who decline participation were excluded from this study resulting in a total primary population 
of 33 providers. All participants are ADN or BSN educated nurses, as this is standing criteria for 
employment as a staff nurse in the unit where the study took place. All ethnicities were included. 
Agency employed nurses who do not regularly work in NBH ICU were excluded.  
The secondary population consists of adult patients, aged 18 years and older, admitted to 
the Norton Brownsboro ICU with a new or existing diagnosis of HF during the study period.  All 
ethnicities are included. This population was to be screened for depression using the PHQ-9 
depression screening instrument by participating nurses.   
Data Collection 
Approvals from the University of Kentucky Institutional Review Board (IRB) and the 
Norton Healthcare Office of Research and Administration (NHORA) were obtained prior to 
implementation and the collection of data.  Patient charts were obtained from the NBH electronic 
patient database.  Charts were identified using the ICD-10 codes associated with any HF 
diagnosis during the study period, this was done by the Norton Healthcare data specialists in the 
Health Information Technologies (HIT) department (Table 1).  During data collection, patient 
records were accessed using the patient medical record numbers (MRN) provided by HIT 
specialist.  A total of 1,012 patient MRNs were returned, eliminating those patients who were 
seen on an outpatient basis reduced the number of MRNs to 157.  The primary investigator (PI) 
entered each of the remaining 157 medical records to assess if the patient had been in NBH’s 
ICU during their hospitalization and if the patient had been under the care of one or more 
participating providers.  A final yield of 34 MRN’s met study criteria for further review.  Of 
those, two were omitted as those patients were admitted with a stroke diagnosis and were 
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therefore screened for depression according to the mandatory protocol already in place.  A total 
of 32 MRN’s were utilized for uses in data analysis. 
 Provider data for analysis consisted of demographic variables: age, education, years 
nursing experience, years ICU nursing experience, gender, ethnicity, and pre/post knowledge and 
perception assessments.  Data obtained from chart review of the secondary population includes: 
number of providers who cared for patient, depression screening completion status, and 
documented reason if screening not completed. 
Data Analysis 
 Descriptive statistics, including means, frequency distribution, and SD were used to 
describe patients’ demographic characteristics. McNemar’s test was used to test for differences 
pre-post for knowledge.  Paired t-test was used to differentiate pre-post assessment of perception 
of comorbid depression in HF.  All analysis was conducted using Statistical Package for the 
Social Sciences (SPSS) version 23; a level of P<.05 was used for statistical significance 
throughout.  
Results 
 The provider sample demographic characteristics as to age, sex, ethnicity, education 
level, and nursing experience can be seen in Table 2.  Posttest knowledge remained unchanged 
aside from one item.  A marked increase of provider knowledge (P =.002) was noted regarding 
the time sensitivity of the PHQ-9 to detect depressive symptoms (Table 3).  Both pre- and post-
test of perception indicates that the participants agree to strongly agree with the three items, 
however posttest indicates a significant increase (P=.001, P=.04) in the level of agreement that 
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Undetected/Untreated depression is both a problem and has a negative impact on the overall 
health of HF patients (Table 4). 
 Analysis of chart data revealed that among those who were screened, patients were in the 
care of an average of 1.6 nurses (SD=2.1, range= 0-6) prior to being screened. Of those who 
were not screened, patients were in the care of an average of 3.2 nurses (SD=4.2, range=0-19) 
prior to being screened.  Depression screening adherence was at 40.6%.  However, for those HF 
patients who were screened for depression it is noted that the patient was in the care of an 
average of 1.6 (SD= 2.1, range 0-6) participating providers prior to being screened.  Non-
adherence was at 59.4%; for those not screened it is noted that those patients were in the care of 
an average of 3.2 (SD= 4.2, range 1-19) participating providers prior to discharge from ICU. 
Discussion 
 This study aimed to determine if a correlation exists between education/knowledge of the 
burdens of comorbid depression in the HF population and adherence to a depression screening 
protocol for that population.  Findings from this study suggest that there is not a correlation 
between knowledge and adherence to depression screening for an adult inpatient ICU population. 
 Despite significant evidence of improved knowledge and increased sensitivity to the 
burden of comorbid depression in HF patients, non-adherence to a depression screening protocol 
existed even when patients were screened.  This is evidenced by the number of participating 
providers who cared for the patient prior to the completion of depression screening; out of the 
40.6% of the secondary population who were screened for depression, an average of 1.6 
participating providers failed to complete depression screening before another provider followed 
the study protocol.  HF patients who were screened for depression according to the study 
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protocol were missed by anywhere from 1 to 6 providers who had volunteered to participate in 
this study before a different participating provider followed protocol.  Only 1 participating 
provider documented a reason for depression screening not being completed, the cited reason 
indicated that the patient had been discharged and readmitted as a Hosparus patient.  As for the 
53.8% of the secondary population who were completely missed by the protocol, they were 
missed by an average of 3.2 participating providers, anywhere from 1 to 19.  Of note, one HF 
patient was under the care of 19 different voluntary participating providers without being 
screened for depression OR having a documented reason for depression screening not being 
completed. 
Prevention is key to improve and preserve population health.  The medical consequence 
of failing to identify those HF patients at with increased risk of poor outcomes due to comorbid 
depression is that providers then miss the opportunity to offer and explore treatment options that 
may improve outcomes.  It is important to note that the study unit at NBH does have a PHQ-9 
depression screening protocol in place for the stroke population, the adherence to depression 
screening related to that protocol is 95%; patients who screen positive have results forwarded to 
their attending physician who then can plan care accordingly (Lindsey R. Siewert, R.N., 
Neuroscience Clinical Nurse Specialist and stroke coordinator at NBH, personal communication 
December 1, 2017).  It stands to reason that a HF specific depression screening protocol could be 
equally adhered to, if made a standardized requirement. 
Limitations 
 The limitations of this study include small sample of participating nurse 
providers, making results less reliable for generalizability.  Implementation results may be 
different if the conducted with a larger provider population.  Pilot period duration was also a 
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limitation.  A longer duration may have changed adherence data and/or perceptions of providers.  
Implementation of the pilot protocol in a single unit was a limitation.  Adherence and perceptions 
may have resulted differently had this protocol been implemented across multiple sites.  
Additionally, this study it limited by the poor generalizability of results due to the study unit 
itself.  The study unit was chosen due to its lower acuity level of cardiac patients as compared to 
other critical care units within Norton Healthcare, allowing for contact with HF patients prior to 
their being lost to discharge.   
 
Recommendations for Future Study 
To further assess what steps are necessary to comprehensively identify HF patients with 
comorbid depression, a large scale multi-unit, multi-level comparison study that includes 
evaluation of factors that contribute to non-adherence of voluntary providers is recommended.  
In the course of this study it was found that limited evidence exists concerning the treatment of 
depression in the HF population.  More research is needed to investigate what care pathways are 
most effective in this population.  Furthermore, research should be focused according to HF 
classifications, as needs and functional ability vary with severity of disease.  Investigation of 
what steps are currently being taken by physicians and APRNs when depression is identified in 
the inpatient HF population.   
Conclusion 
Recommendations to screen the adult population for depression have been issued by 
USPSTF and recommendations to screen for depression the HF population have been found in 
international HF guidelines and current research [(Siu, 2016); (SIGN 2016); (Rustad et al., 
2013).  The US Guidelines have yet to adopt this measure as a requirement (Yancy et al., 2017).  
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Is this because the evidence for the most appropriate and effective treatment is lacking?  Or is it 
because the resources are not in place to manage the burden of treatment that comes with 
identification of the problem?   
In the absence of standardized U.S. guidelines that call for depression screening, this 
study aimed to determine if a correlation exists between knowledge and sensitivity to the burden 
of HF with coexisting depression and adherence to a pilot depression screening protocol.  
Despite increased sensitivity in the perception of depression as a burdensome healthcare factor in 
the HF population poor adherence to the pilot protocol resulted.   
HF is a complex health issue that contributes a massive burden on the healthcare 
community (AHA, 2017).  An important and pervasive contributor to the poor outcomes 
associated with HF has been identified as worsening symptoms of depression (Sherwood, 
Andrew, Blumenthal, James & Hinderliter, 2011).  We have valid and reliable instruments to 
identify depression in HF patients.  
The healthcare community continues to search for the most appropriate and agreed upon 
treatment for depression in the HF population. There is evidence to suggest that cognitive 
behavioral therapy (CBT) targeted towards depression and HF self-care is effective for 
depression but not for HF self-care or physical functioning; however other benefits result, such 
as reduced anxiety and fatigue, improved social functioning, and better quality of life as related 
to health (O'Malley, 2015).  Further evidence asserts that there is limited evidence specific to the 
treatment of depression in the HF population but supports CBT and pharmacologics such as 
selective serotonin reuptake inhibitors (SSRIs), as safe and effective for the reduction of 
depressive symptom severity in cardiovascular patients (Rustad et al., 2013). 
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In the absence of official US Guideline recommendations that call for screening of all HF 
patients for depression, healthcare facilities can incorporate a standardized screening protocol to 
identify depression in the adult inpatient HF population so that treatment decisions can be made. 
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Table 1. Inclusion List of Heart Failure ICD-10 Codes 
 
Inclusion Criteria List of Heart Failure ICD-10 Codes 
ICD-10 
Codes  
Diagnosis Definition  
I11.0 Hypertensive heart disease with heart failure 
I13.0 Hypertensive heart and chronic kidney disease with heart failure and stage 1 
through stage 4 chronic kidney disease, or unspecified chronic kidney disease 
I13.2 Hypertensive heart and chronic kidney disease with heart failure and with stage 5 
chronic kidney disease, or end stage renal disease 
I50.20 Unspecified systolic (congestive) heart failure 
I50.21 Acute systolic (congestive) heart failure 
I50.22 Chronic systolic (congestive) heart failure 
I50.23 Acute on chronic systolic (congestive) heart failure 
I50.30 Unspecified diastolic (congestive) heart failure 
 
I50.31 Acute diastolic (congestive) heart failure 
 
I50.32 Chronic diastolic (congestive) heart failure 
I50.33 Acute on chronic diastolic (congestive) heart failure 
I50.41 Acute combined systolic (congestive) and diastolic (congestive) heart failure 
 
I50.42 Chronic combined systolic (congestive) and diastolic (congestive) heart failure 
I50.43 Acute on chronic combined systolic (congestive) and diastolic (congestive) heart 
failure 
 
I50.9 Heart failure, unspecified 
I42.90 Cardiomyopathy  
Table 2. Nurse Participant Demographics n=33 
 Mean (SD) or n (%) 
Age 34.9 (9.7) 
Education 
   ADN 
   BSN 
 
6 (18%) 
27 (82%) 
Years experience as a nurse 7.2 (8.7) 
Years experience as an ICU nurse 6 (8.1) 
Gender 
   Female 
   Male 
 
24 (73%) 
9 (27%) 
Race 
   Black or African American 
   Caucasian 
   American Indian/ Alaskan Native 
   Asian 
   Hispanic 
    
 
1 (3%) 
30 (91%) 
0 
0 
2 (6%) 
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Table 3. Pre-post Knowledge Assessment n=33 
 
 Pre 
% correct 
Post 
% correct 
p 
The PHQ-9 tool is 
used to assess for 
what condition? 
Depression 
100% 100% NA 
How do you access 
the PHQ-9 tool for 
patient assessment? 
Flowsheets 
100% 100% NA 
The PHQ-9 monitors 
for symptoms of 
depression that have 
been present for: 2 
Weeks 
46% 85% .002 
Symptoms of 
depression have no 
effect on self-
efficacy or 
adherence to 
medical treatment. 
False 
98% 98% NA 
 
 
 
Table 4. Pre-post Perception Assessment of Untreated/ Undetected Depression n=33 
 Pre 
Mean (SD) 
Post 
Mean (SD) 
p 
Is a problem in the 
heart failure patient 
population 
2.1 (1.1) 1.4 (0.7) .001 
Negatively impacts 
the overall health of 
individual heart 
failure patients 
1.8 (1.3) 1.4 (0.7) .04 
Negatively impacts 
medical compliance 
of individual heart 
failure patients 
1.9 (1.3) 1.4 (0.7) .09 
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Appendix A 
 
Assessment of Knowledge 
1. The PHQ-9 tool is used to assess for what condition? 
a. Obstructive sleep apnea 
b. Suicide risk 
c. Depression 
d. AMI risk 
2. How do you access the PHQ-9 tool for patient assessment? 
a. Navigator 
b. Chart Review 
c. Results Review 
d. Flowsheets 
3. The PHQ-9 monitors for symptoms of depression that have been present for:  
a.  1-month  
b. 1-week   
c.  2-months   
d.  2-weeks 
4. Symptoms of depression have no effect on self-efficacy or adherence to medical 
treatment. 
a. True 
b. False 
 
How strongly do you agree or disagree with each of the following:  
1-Strongly agree  
2- Agree  
3- Neither agree nor disagree  
4- Disagree  
5- Strongly disagree  
 
 Untreated/undetected depression:             
a. Is a problem in the heart failure patient population? 1 2 3 4 5  
b. Negatively impacts the overall health of individual heart failure patients? 1 2 3 4 5  
c. Negatively impacts medical compliance of individual heart failure patients? 1 2 3 4 5 
 
